HI-62
Research-use ionizable lipid with product-specific formulation context.
View product →
cationic/ionizable lipids · in vivo car research products
Patent-reported ionizable lipid for spleen-targeted mRNA-LNP research.
Lipid 43 is an ionizable lipid disclosed as Compound 43 in WO 2024/109794. In the patent's TMF30 formulation, mRNA-LNPs showed predominantly splenic reporter expression after administration in mice. Its structure, molecular formula, molecular weight and SMILES were assigned from the compound-specific synthesis scheme and checked against the reported proton count.
| CAS No. | Not available |
| Chemical Name | Lipid 43 |
| SMILES | CCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCC(=O)OCC(COC(=O)CCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)N(C)CCO |
| Formula | C56H107NO9 |
| M.Wt | 938.47 |
| Purity | >98% |
| Storage | Contact us for batch-specific storage and handling guidance. |
| Shipping condition | Ships from Shanghai. Contact us to confirm the appropriate transport condition for the current batch. |
| Product classification | Cationic/Ionizable Lipids; In vivo CAR research products |
| Component | Reported mol% | Role |
|---|---|---|
| Lipid 43 | 46.3 | Ionizable lipid |
| DOPE | 9.4 | Helper phospholipid |
| Cholesterol | 42.7 | Sterol |
| PEG2000-DMG | 1.6 | PEG lipid |
| Total | 100.0 | Original patent ratio retained |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.6504 mL | 2.3301 mL | 1.1650 mL |
| 25 mg | 29.1260 mL | 5.8252 mL | 2.9126 mL |
| 50 mg | 58.2520 mL | 11.6504 mL | 5.8252 mL |
| 100 mg | 116.5039 mL | 23.3008 mL | 11.6504 mL |
| 250 mg | 291.2599 mL | 58.2520 mL | 29.1260 mL |
Contact our team with the catalog number and requested quantity.